| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 胶囊(元) | 64,031,655.25 | 104,979,254.46 | 64,200,711.16 |
| 片剂(元) | 438,322,481.11 | 828,583,931.94 | 449,918,783.82 |
| 全品种(元) | - | - | 47,752,633.58 |
| 丸剂(元) | 64,345,191.61 | 124,377,373.11 | 46,546,231.98 |
| 针剂(元) | 114,773,127.26 | 193,533,351.56 | 111,597,713.06 |
| 颗粒剂(元) | 15,820,427.63 | 24,566,001.20 | - |
| 其他类药物(元) | 34,215,199.82 | 60,114,537.60 | 24,624,114.11 |
| 营业成本(元) | |||
| 胶囊(元) | 33,503,817.22 | 60,292,922.40 | 35,438,370.51 |
| 片剂(元) | 157,357,091.21 | 330,290,001.89 | 161,694,628.56 |
| 全品种(元) | - | - | 31,865,846.20 |
| 丸剂(元) | 16,898,060.21 | 47,648,500.04 | 20,398,798.29 |
| 针剂(元) | 48,764,463.91 | 89,729,634.12 | 52,564,503.63 |
| 颗粒剂(元) | 12,555,299.10 | 18,343,874.68 | - |
| 其他类药物(元) | 29,697,907.84 | 54,057,615.16 | 24,486,699.97 |
| 毛利(元) | |||
| 胶囊(元) | 30,527,838.03 | 44,686,332.06 | 28,762,340.65 |
| 片剂(元) | 280,965,389.90 | 498,293,930.05 | 288,224,155.26 |
| 全品种(元) | - | - | 15,886,787.38 |
| 丸剂(元) | 47,447,131.40 | 76,728,873.07 | 26,147,433.69 |
| 针剂(元) | 66,008,663.35 | 103,803,717.44 | 59,033,209.43 |
| 颗粒剂(元) | 3,265,128.53 | 6,222,126.52 | - |
| 其他类药物(元) | 4,517,291.98 | 6,056,922.44 | 137,414.14 |
| 毛利率(%) | |||
| 胶囊(%) | 47.68 | 42.57 | 44.80 |
| 片剂(%) | 64.10 | 60.14 | 64.06 |
| 全品种(%) | - | - | 33.27 |
| 丸剂(%) | 73.74 | 61.69 | 56.18 |
| 针剂(%) | 57.51 | 53.64 | 52.90 |
| 颗粒剂(%) | 20.64 | 25.33 | - |
| 其他类药物(%) | 13.20 | 10.08 | 0.56 |
| 收入构成(%) | |||
| 胶囊(%) | 8.75 | 7.86 | 8.62 |
| 片剂(%) | 59.92 | 62.01 | 60.42 |
| 全品种(%) | - | - | 6.41 |
| 丸剂(%) | 8.80 | 9.31 | 6.25 |
| 针剂(%) | 15.69 | 14.48 | 14.99 |
| 颗粒剂(%) | 2.16 | 1.84 | - |
| 其他类药物(%) | 4.68 | 4.50 | 3.31 |
| 毛利构成(%) | |||
| 胶囊(%) | 7.05 | 6.07 | 6.88 |
| 片剂(%) | 64.93 | 67.72 | 68.92 |
| 全品种(%) | - | - | 3.80 |
| 丸剂(%) | 10.96 | 10.43 | 6.25 |
| 针剂(%) | 15.25 | 14.11 | 14.12 |
| 颗粒剂(%) | 0.75 | 0.85 | - |
| 其他类药物(%) | 1.04 | 0.82 | 0.03 |